About Anoctamin-5-related limb-girdle muscular dystrophy R12
Anoctamin-5-related limb-girdle muscular dystrophy R12 is a rare disease catalogued by Orphanet (ORPHA:206549). It is associated with the ANO5 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Anoctamin-5-related limb-girdle muscular dystrophy R12 trials.
Search ClinicalTrials.gov for "Anoctamin-5-related limb-girdle muscular dystrophy R12" or filter by Orphanet code ORPHA:206549 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Anoctamin-5-related limb-girdle muscular dystrophy R12 trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Anoctamin-5-related limb-girdle muscular dystrophy R12. Updated daily.